Michael Allred, MD
Family Medicine · Layton, UTNPI 1811973829
Payments from drug & device makers
Across 405 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$866
- Lilly USA, LLC$620
- Amgen$609
- Boehringer Ingelheim$441
- AstraZeneca$414
- GSK$390
- plus $3K from 49 others
Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Lucid Diagnostics Inc.$500
What the payments were for
- Food & beverage$6,171100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,189 in reported general payments places this provider in the 85th percentile of 928 family medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 149 | $182,385 |
| JardianceEmpagliflozin | 72 | $87,472 |
| MyrbetriqMirabegron | 100 | $67,626 |
| TrulicityDulaglutide | 29 | $53,198 |
| OzempicSemaglutide | 42 | $47,958 |
| JanuviaSitagliptin Phosphate | 22 | $37,590 |
| FarxigaDapagliflozin Propanediol | 23 | $34,833 |
| EliquisApixaban | 19 | $27,554 |
| XareltoRivaroxaban | 19 | $22,734 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $21,781 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $19,503 |
| Tresiba Flextouch U-100Insulin Degludec | 24 | $18,943 |
| VraylarCariprazine Hcl | 12 | $16,458 |
| Spiriva RespimatTiotropium Bromide | 15 | $10,048 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $8,940 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $620 | $235,583178 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $441 | $103,62299 claims |
| Astellas Pharma US IncMyrbetriq | $173 | $67,626100 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $414 | $61,69271 claims |
| Novo NordiskOzempic | $96 | $47,95842 claims |
| MerckJanuvia | $67 | $37,59022 claims |
| PfizerEliquis | $226 | $27,55419 claims |
| AbbVieVraylar, Linzess | $866 | $23,08824 claims |
| Johnson & JohnsonXarelto | $133 | $22,73419 claims |
| GSKTrelegy Ellipta | $390 | $8,94014 claims |
| Sanofi-aventis U.S. LLCLantus | $112 | $4,15311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 928 family medicine providers in Utah.
Other family medicine in Layton
- Marc AndersonLayton$2.8M
- Jeffery DegrauwLayton$921K
- Kurtis WoolfLayton$224K
- Courtney NelsonLayton$190K
- David ButtersLayton$189K
- John HemmersmeierOgden$24.9M
- Judith KirsteinWest Jordan$22.7M
- Matthew JohnstonSalt Lake City$20.9M
- Jared ProbstSalt Lake City$18.8M
- Bryce PetersonBountiful$16M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.